Repare Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Repare Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2024.
  • Repare Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $2.2M, a 50.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.2M -$2.24M -50.5% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $2.76M -$2.21M -44.5% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.33M -$2.05M -38.1% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $3.88M -$2.02M -34.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.43M -$2.02M -31.3% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $4.98M -$2.03M -28.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $5.37M -$2.12M -28.3% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $5.9M -$1.35M -18.6% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $6.46M +$1.83M +39.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $7M +$2.7M +62.7% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $7.49M +$2.82M +60.3% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $7.25M +$2.23M +44.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $4.63M +$3.9M +535% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $4.3M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $4.67M +$3.64M +352% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $5.02M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $729K Jun 30, 2020 10-Q 2020-08-13
Q4 2019 $1.03M Dec 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.